Summary
A large dose of 24R,25(OH)2D3 was administered to the vitamin D-repleted rat to examine its effect on the bone. Male Wistar rats were fed a diet containing 0, 0.025, 1.25, 4.0, and 12.5 ppm 24R,25(OH)2D3 for 2 years starting at age 6 weeks. The estimated amounts of daily intake of 24R,25(OH)2D3 were 0, 93, 4640, 14680, and 49580 ng/100 g body weight, respectively. No notable difference was found in either the weight or the death rate of the animal. The long-term administration of massive doses of 24R,25(OH)2D3 did not lead to hypercalcemia nor did it affect the blood phosphorus, alkaline-phosphatase, or creatinine levels. Radiographs revealed a striking increase in the bone density on the bones from the animals treated with 1.25 ppm or more 24R,25(OH)2D3. Direct single photon absorptiometry revealed a dose-dependent increase in total bone minerals of both the femur and coccyx. Histological examination revealed a marked increase in the cortical thickness of the femur as well as in the cancellous bone volume of the coccyx. Polarizing microscopy demonstrated the lamellar structure of the bone, and undecalcified sections confirmed the increase of mineralized bone. Ash weight, calcium, phosphorus, and magnesium contents on the tibia and fibula also indicated the ascending dose-dependent increase up to 150% of the control. The parameters of bone size were not altered in any group. These results clearly suggest that 24R,25(OH)2D3 given in massive doses has the pharmacological action of increasing bone volume in the rat without causing remarkable hypercalcemia.
Similar content being viewed by others
References
Walters MR, Hunziker W, Norman AW (1981) Ubiquitous effects of the vitamin D endocrine system. Trends In Pharmacolog Sci 2:42–44
Chan YL, Mason RS, Parmentier M, Savdie E, Lissner D, Posen D (1983) Vitamin D metabolism in nephrotic rats. Kidney Int 24:336–341
Parfitt AM, Mathew CHE, Brommage R, Jarnagin K, DeLuca HF (1984) Calcitriol but no other metabolite of vitamin D is essential for normal bone growth and development in the rat. J Clin Invest 73:576–586
Tanaka Y, DeLuca HF, Kobayashi Y, Taguchi T, Ikekawa N, Morisaki M (1979) Biological activity of 24,24-difluoro-25-hydroxyvitamin D3. Effect of blocking of 24-hydroxylation on the functions of vitamin D. J Biol Chem 254:7163–7167
Corvol MT, Dumontier MF, Garabedian B, Rapport R (1978) Vitamin D and cartilage. II. Biological activity of 25-hydroxycholecalciferol and 24,25- and 1,25-dihydroxycholecalciferols on cultured growth plate chondrocytes. Endocrinology 102:1209–1274
Endo H, Kiyoki M, Kawashima K, Naruchi T (1980) Vitamin D3 metabolites and PTH synergistically stimulate bone formation of chick embryonic femur in vitro. Nature 286:262–264
Gordeladze JE, Gautvik KM (1986) Hydroxycholecalciferols modulate parathyroid hormone and calcitonin-sensitive adenylyl cyclase in bone and kidney of rats, a possible physiological role for 24,25-dihydroxyvitamin D3. Biochem J 217:899–902
Henry HL, Norman AW (1978) Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability. Science 210:835–837
Mahgoub A (1981) Interaction between 24R,25-dihydroxycholecalciferol and 1,25-dihydroxycholecalciferol on45Ca release from bone in vitro. Calcif Tissue Int 33:663–666
Ornoy A, Goodwin D, Noff D, Edelstein S (1978) 24,25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation. Nature 276:517–519
Sömjen D, Binderman I, Weisman Y (1983) The effects of 24R,25-dihydroxycholecalciferol and 1 alpha, 25-dihydroxycholecalciferol on ornithine decarboxylase activity and DNA synthesis in the epiphysis and diaphysis of rat bone in the duodenum. Biochem J 214:293–298
Tam CS, Heershe J, Jones G, Murray TM, Rasmussen H (1986) The effect of vitamin D on bone in vivo. Endocrinology 118:2217–2224
Wientroub S, Price PA, Reddi AH (1987) The dichotomy in the effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone gamma-carbocyglutamic acid-containing protein in serum and bone in vitamin D-deficient rats. Calcif Tissue Int 40:166–172
Wilhelm F, Ross FP, Norman AW (1986) Specific binding of 24R,25-dihydroxyvitamin D3 to chick intestinal mucosa: 24R,25-dihydroxyvitamin D3 is an allosteric effector of 1,25-dihydroxyvitamin D3 binding. Arch Biochem Biophy 249:88–94
Manolagas SC, Deftos LJ (1981) Comparison of 1,25-,25-, and 24,25-hydroxylated vitamin D3 binding in fetal rat calvariae and osteogenic sarcoma cells. Calcif Tissue Int 33:655–661
Connerty HV, Briggs AR (1966) Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol 45:290–296
Hagaman JR, Sanchez TV, Myers RC (1985) The effect of lactation on the mineral distribution profile of the rat femur by single photon absorptiometry. Bone 6:301–305
Rice E, Lapara CZ (1963) Rapid ultramicrospectrophotometric determination of magnesium. Clin Chim Acta 10:360–364
Hass GM, Trueheart RE, Taylor CB, Stumpe M (1958) An experimental histologic study of hypervitaminosis D. Am J Pathol 34:395–431
Schneider H, Steenbock H (1939) A low phosphorus diet and the response of rats of vitamin D2. J Biol Chem 128:159–171
Gallagher JA, Lawson DEM (1980) Histological observations on the failure of rachitic rat bones to respond to 1,25(OH)2D3. Calcif Tissue Int 31:215–223
Hartenbower DL, Stanley TM, Coburn JW, Norman AW (1977) Serum and renal histologic changes in the rat following administration of toxic amounts of 1,25(OH)2D3. In: Norman AW, Schaefer K, Coburn JW, DeLuca HF, Fraser D, Grigoleit HG, Herrath DV (eds) Vitamin D: biochemical, chemical and clinical aspects related to calcium metabolism. Walter de Gruyter, Berlin, pp 587–589
Queille ML, Miravet LM, Bordier P, Redel J (1978) The action of vitamin D metabolites (25(OH)D3, 1,25(OH)2D3, 24,25(OH)2D3, 25,26(OH)2D3) on vitamin D-deficient rats. Biomedicine 28:237–242
Day GG, Follis RH (1941) Skeletal changes in rats receiving estradiol benzoate as indicated by histological studies and determinations of bone ash, serum calcium and phosphatase. Endocrinology 28:83–93
Foster GV, Doyle FH, Bordier PB, Matrajt H, Tun-Chot S (1967) Roentgenologic and histologic changes in bone produced by thyrocalcitonin. Am J Med 43:691–695
Wase AW, Solewski J, Rickes E, Seidenberg J (1967) Action of thyrocalcitonin on bone. Nature 214:388–389
Kalu DN, Pennock J, Doyle FH, Foster GV (1970) Parathyroid hormone and experimental osteosclerosis. Lancet (i):1363–1366
Schenk R, Merz WZ, Muhlbauer R, Russell RGG, Fleisch H (1973) Effect of ethane-1-hydroxy-1,1-diphosphonate(EHDP) and dichloromethylene diphosphonate(Cl2MDP) on the calcification and resorption of cartilage metaphysis of rats. Calcif Tissue Int 11:196–214
Urist MR, Budy AM, McLean FC (1950) Endosteal-bone formation in estrogen-treated mice. J Bone Joint Surg 32A:143–162
Aceitero J, Gaytan F, Ranz FB (1987) Effects of neonatal estrogenization on rat bone development: a histomorphometric study. Calcif Tissue Int 40:189–193
Holick MF, Baxter LA, Scraufrogel PK, Tavela TE, DeLuca HF (1976) Metabolism and biological activity of 24,25-dihydroxyvitamin D3 in the chick. J Biol Chem 251:397–402
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakamura, T., Kurokawa, T. & Orimo, H. Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3 . Calcif Tissue Int 43, 235–243 (1988). https://doi.org/10.1007/BF02555140
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02555140